STOCK TITAN

Altimmune (ALT) Revenue by Year

ALT

Altimmune generated $41K in revenue in fiscal year 2025. This represents an increase of 105.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Altimmune has filed alongside them.

FY2025 annual
Revenue $41K
YoY +105.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALT Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$41K+105.0%$20K-95.3%$426KN/A$4.4M-46.1%$8.2M+41.1%$5.8M-43.8%$10.3M-3.8%$10.7M+231.8%$3.2MN/AN/AN/AN/A$24.3M

ALT Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
RevenueN/AN/A$26K+420.0%$5K0.0%$5K0.0%$5K0.0%$5K-86.5%$5K-98.6%$5K-16.7%$5K-76.2%$37K$362K+18000.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Altimmune financials

Frequently Asked Questions

What was Altimmune's revenue in fiscal year 2025?

Altimmune generated $41K in revenue in fiscal year 2025.

How fast is Altimmune's revenue growing?

Altimmune (ALT) revenue rose by 105.0% year over year, from $20K to $41K in fiscal year 2025.

How has Altimmune's revenue changed over the years?

Across the 15 fiscal years this page covers, Altimmune (ALT) revenue went from $24.3M in fiscal year 2011 to $41K in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Altimmune (ALT) reported on that line in every period on record.